Transcription of GLI GUIDE - Stop TB Partnership
{{id}} {{{paragraph}}}
GLI GUIDE to TB Specimen Referral Systems and Integrated NetworksGLI GUIDE to TB Specimen Referral Systems and Integrated NetworksiiiContentsCONTENTSA cknowledgements vAbbreviations viiBackground 1 Coordination of a Specimen Referral System 3 Planning for a Specimen Referral System 4 Phase 1: Detailed situational assessment of current specimen referral systems 4 Phase 2: Design of a specimen referral system pilot 5 Phase 3: Setup and implementation of pilot 5 Phase 4: Review of pilot 6 Phase 5: Scale-up of the specimen referral system 6 Phase 6: Ongoing monitoring and evaluation, and continuous improvement 6 Key System Design Components 7 Management 7 Adequate laboratory testing capacity 7 Confidentiality of patient information 8 Transport options 8 Logistics and scheduling 8 Results return 9 Documentation including SOPs 9 Training and sensitization 10 Communication 10 Monitoring and evaluating quality and system performa
1 Background BACKGROUND The WHO End TB Strategy calls for the early diagnosis of TB and universal drug-susceptibility testing (DST), with ambitious targets that can only be achieved when
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Drug Testing, Human, Drug, Testing, Practice Guidelines for Prenatal Laboratory, Guidelines for Prenatal Laboratory Screening, Local Coverage Determination for Qualitative Drug, Policy, Getting Started with Medication-assisted Treatment Getting Started with Medication-assisted Treatment, SOUTH AFRICA: COUNTRY, SOUTH AFRICA: COUNTRY REPORT FOCUSSING, For Blood Storage Centre, The effects of education on health